ATE169637T1 - Derivate des dolastatin - Google Patents

Derivate des dolastatin

Info

Publication number
ATE169637T1
ATE169637T1 AT93909931T AT93909931T ATE169637T1 AT E169637 T1 ATE169637 T1 AT E169637T1 AT 93909931 T AT93909931 T AT 93909931T AT 93909931 T AT93909931 T AT 93909931T AT E169637 T1 ATE169637 T1 AT E169637T1
Authority
AT
Austria
Prior art keywords
dolastatin
derivatives
novel
derivates
formula
Prior art date
Application number
AT93909931T
Other languages
English (en)
Inventor
Andreas Haupt
Franz Emling
Cynthia Romerdahl
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of ATE169637T1 publication Critical patent/ATE169637T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT93909931T 1992-05-20 1993-05-10 Derivate des dolastatin ATE169637T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88578892A 1992-05-20 1992-05-20
US98569692A 1992-11-25 1992-11-25

Publications (1)

Publication Number Publication Date
ATE169637T1 true ATE169637T1 (de) 1998-08-15

Family

ID=27128772

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93909931T ATE169637T1 (de) 1992-05-20 1993-05-10 Derivate des dolastatin

Country Status (21)

Country Link
EP (1) EP0642530B1 (de)
JP (2) JP3523253B2 (de)
KR (1) KR100286242B1 (de)
CN (1) CN1065874C (de)
AT (1) ATE169637T1 (de)
AU (1) AU669710B2 (de)
CA (1) CA2136339C (de)
CZ (1) CZ292612B6 (de)
DE (1) DE69320339T2 (de)
DK (1) DK0642530T3 (de)
ES (1) ES2118955T3 (de)
FI (1) FI120692B (de)
HU (2) HUT71398A (de)
IL (1) IL105651A (de)
MX (1) MX9302927A (de)
NO (1) NO310465B1 (de)
NZ (1) NZ252147A (de)
RU (1) RU2116312C1 (de)
SI (1) SI9300267A (de)
UA (1) UA45304C2 (de)
WO (1) WO1993023424A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
DE4415997A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neuer peptidischer Wirkstoff und dessen Herstellung
DE4415998A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neue Tetrapeptide, ihre Herstellung Verwendung
DE19527575A1 (de) * 1995-07-28 1997-01-30 Basf Ag Verfahren zur Herstellung von peptidischer Wirkstoffe
DE19527574A1 (de) * 1995-07-28 1997-01-30 Basf Ag Verfahren zur Herstellung vona-(N,N-Dialkyl)-aminocaarbonsäureamiden
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof
AU775090B2 (en) * 1995-12-15 2004-07-15 Abbvie Deutschland Gmbh & Co Kg Antineoplastic peptides
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US20010009901A1 (en) 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US5939527A (en) * 1996-07-30 1999-08-17 Basf Aktiengesellschaft Tetrapeptides as antitumor agents
US5741892A (en) * 1996-07-30 1998-04-21 Basf Aktiengesellschaft Pentapeptides as antitumor agents
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6143721A (en) 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6686445B1 (en) 1997-09-24 2004-02-03 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
EP1049481B1 (de) * 1997-09-24 2005-04-20 Arizona Board Of Regents Synthetische antineoplastische wirkstoffe abgeleitet von dolastatin 15 sowie verfahren zu ihrer herstellung
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
ES2318167T3 (es) * 2002-07-15 2009-05-01 The Trustees Of Princeton University Compuestos de union a iap.
WO2005051372A2 (en) 2003-11-24 2005-06-09 Teva Gyógyszergyár Zártköruen Muködo Részvénytársaság Method of purifying pravastatin
WO2023033129A1 (ja) 2021-09-03 2023-03-09 東レ株式会社 癌の治療及び／又は予防用医薬組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
DE69230824T2 (de) * 1991-08-09 2000-07-27 Teikoku Hormone Mfg Co Ltd Neue tetrapeptidderivate

Also Published As

Publication number Publication date
JP3523253B2 (ja) 2004-04-26
NO944419L (no) 1995-01-09
JP2004149538A (ja) 2004-05-27
WO1993023424A1 (en) 1993-11-25
RU2116312C1 (ru) 1998-07-27
NZ252147A (en) 1996-10-28
DE69320339T2 (de) 1998-12-17
DK0642530T3 (da) 1998-10-26
RU94046434A (ru) 1996-10-27
IL105651A (en) 1998-07-15
UA45304C2 (uk) 2002-04-15
CZ292612B6 (cs) 2003-11-12
CN1085563A (zh) 1994-04-20
HU211745A9 (en) 1995-12-28
CZ284394A3 (en) 1995-05-17
CA2136339C (en) 2008-02-05
SI9300267A (sl) 1993-12-31
FI120692B (fi) 2010-01-29
FI945416A0 (fi) 1994-11-17
CA2136339A1 (en) 1993-11-25
MX9302927A (es) 1993-11-01
DE69320339D1 (de) 1998-09-17
IL105651A0 (en) 1993-09-22
NO310465B1 (no) 2001-07-09
NO944419D0 (no) 1994-11-18
ES2118955T3 (es) 1998-10-01
EP0642530A1 (de) 1995-03-15
CN1065874C (zh) 2001-05-16
EP0642530B1 (de) 1998-08-12
AU669710B2 (en) 1996-06-20
JPH07506580A (ja) 1995-07-20
AU4066293A (en) 1993-12-13
KR100286242B1 (ko) 2001-04-16
HUT71398A (en) 1995-11-28
FI945416A (fi) 1994-11-17

Similar Documents

Publication Publication Date Title
DE69320339D1 (de) Derivate des Dolastatin
MY124487A (en) Dolastatin derivatives, their preparation and use
FI952961A (fi) Dolostatiinianalogeja
FI933568A0 (fi) 9-((substituerad glycyl)amido)-6-demetyl-6-deoxitetracykliner
ATE267164T1 (de) 9-(substituiertes glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxy etracycline
AU4755393A (en) Azaquinoxalines, processes for their preparation and their use
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
FI930051A0 (fi) 4,13-dioxabicyklo(8.2.1)tridecenonderivat sam foerfarande och mellanprodukt foer deras framstaellning
EA199900534A1 (ru) Имидазопиридазины
BG98238A (en) Substituted benzothiazole derivatives, methods for their preparation and their application as herbicides
MY114327A (en) Novel peptides, the preparation and use thereof
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
EE9400233A (et) 1,5,6,7-tetrahüdro-4H-indasool-4-ooni sisaldav ravim, uus 1,5,6,7-tetrahüdro-4H-indasool-4-oon ja meetodid nende saamiseks
PE61999A1 (es) Compuestos de tetrahidropiridina
TH14157EX (th) เฟนิลเบนแซมีดสำหรับฆ่าราและกรรมวิธีสำหรับเตรียมสารนั้น
CA2195663A1 (en) Dihydrobenzofuranes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification